e-learning
resources
Conferences
Lung Science Conference
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
PP201 – Therapeutic targeting of iBALT induces lung regeneration in COPD
Thomas Conlon, Germany
Source:
ERS Lung Science Conference 2021
Number:
71
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
Thomas Conlon, Germany. PP201 – Therapeutic targeting of iBALT induces lung regeneration in COPD. ERS Lung Science Conference 2021
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
The Relationship Between Functional Status and Fatigue After COVID-19 Infection
European Respiratory Society guideline on long term management of children with bronchopulmonary dysplasia
PP306 – Submicroscopic changes of type I alveolocytes in the early stages of experimental diabetes mellitus
Related content which might interest you:
Stem cell therapy attenuates airway and lung parenchyma remodeling in a murine model of chronic allergic asthma
Source: Annual Congress 2008 - Recent advances in the treatment and pathogenesis of asthma
Year: 2008
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2013; 42: 350-361
Year: 2013
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2014; 43: 1208-1211
Year: 2014
Simvastatin inhibits smoke-induced airway epithelial injury: implications for COPD therapy
Source: Eur Respir J 2014; 43: 1211-1212
Year: 2014
P2RX4 signalling enhances acute cigarette smoke-induced lung inflammation and chronic lung emphysema development
Source: International Congress 2019 – Airway inflammation: pharmacological mechanisms and novel targets
Year: 2019
Curcumin inhibits COPD-like airway inflammation and lung cancer promotion in mice
Source: Annual Congress 2009 - COPD and asthma - from the cell to the clinic
Year: 2009
Ghrelin ameliorates bleomycin-induced acute lung injury by protecting alveolar epithelial cells and suppressing lung inflammation
Source: Annual Congress 2012 - Fibrogenesis between epithelial injury and fibroblast proliferation
Year: 2012
Effects of autophagy on LPS-induced lung inflammation and acute lung injury (ALI) in vitro and in vivo
Source: International Congress 2018 – Role of microbial exposure and inflammation in lung injury
Year: 2018
Role of dendritic cell subsets in the early stage of cigarette smoke-induced lung inflammation
Source: Annual Congress 2013 –COPD: experimental biology
Year: 2013
Role of Inducible bronchial-associated lymphoid tissue (iBALT) in airway remodelling of murine chronic asthma model
Source: International Congress 2019 – Revealing novel asthma immunopathology endotypes
Year: 2019
Reduction of lung injury and fibrosis by human embrionic stem cells in a mouse model of silica-induced lung fibrosis
Source: Annual Congress 2011 - Experimental models and research in diffuse parenchymal lung diseases
Year: 2011
Effects of autologous mesenchymal stromal cell treatment for severe emphysema on lung tissue: A clinical trial
Source: International Congress 2015 – The multiple facets of stem and progenitor cells in lung health and disease
Year: 2015
TD-0903, an inhaled JAK inhibitor in development for COVID-19, blocks ARDS-relevant hyperinflammation and lung injury in primary human immune and airway epithelial cells
Source: Virtual Congress 2021 – Emerging respiratory diseases: state-of-the-art studies of SARS-CoV-2 infection
Year: 2021
Preferential activation of alveolar macrophages versus epithelial cells during initiation of ventilator-induced lung injury in mice
Source: Annual Congress 2011 - Lung cell injury and repair
Year: 2011
Role of alveolar macrophages in acute lung injury model
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Novel protective role of alveolar macrophages in adaptation to lung injury.
Source: International Congress 2017 – Anti-inflammatory and pro-repair mediators in acute lung injury
Year: 2017
Monitoring of lung function and bronchial inflammation after bone marrow transplantation: preferential recruitment of lymphocytes into the airways
Source: Annual Congress 2006 - Immunological mechanisms in cell recruitment to the lungs
Year: 2006
Oral presentation: Stem cells are dispensable for lung homeostasis but restore airways after injury
Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis
Year: 2009
PAR-2 agonists induce TGF-beta and EMT leading to lung fibrosis
Source: Annual Congress 2013 –Growth factors at the crossroads of acute and chronic inflammation
Year: 2013
B cells drive iBALT formation in a mouse model of chronic lung allograft dysfunction
Source: International Congress 2018 – Lung transplant science: from primary graft to chronic allograft dysfunction
Year: 2018
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept